Search Results

what constitutes a historical sample dr megan rowley consultant haematologist behalf bcsh compatibility guidelines writing groups there much discussion about second group check sample what counts a first historical sample possible scenarios defining a historical sample suitable providing compatible blood at previous sample same patient identification or transfusion policy patient identification number patient administration system laboratory information management system hospitals merge patholog

roles responsibilities support workers hospital blood transfusion chris elliott haematology services manager james cook university hospital friarage hospital division pathology why matter oh a changing 1 technology e g testing automation fridges scanners wireless networks 2 electronic issue ei remote electronic issue rei issue fridge control bedside systems 3 pathology modernisation e g centralisation skill mix savings targets division pathology national pressure skill mix skills health working

the reality consultant transfusion clinical scientist sharran grey principal clinical scientist blood transfusion clinical lead my background key milestones progressed senior roles haematology transfusion further qualifications developed increasingly clinical senior scientific role whilst registered biomedical scientist exploring options frcpath support ongoing clinical development registered a clinical scientist by ahcs equivalence route hsst in service post offered national benchmarking assess

pas plasma pieter f van der meer sanquin blood bank unit production sanquin research clinical transfusion research 1 sanquin 2015 2 collections issues 2014 441 000 264 000 433 000 56 000 57 000 297 000 red cells whole blood donations apheresis donations mostly plasma red cell concentrates issued platelet concentrates units ffp kilo plasma fractionation platelets 3 platelet production 2014 platelet concentrates 56 202 buffy coat pools about 20 pas 80 plasma 3 230 apheresis units 5 4 hla matched r

national randomised trial hla epitope matched platelet transfusions alloimmunised patients myeloid bone marrow disorders marsh jcw kallon d brown c gilbertson a pigden c deary aj mora a brown j laing e pankhurst l choo l hodge r llewelyn c harding k sage d mijovic a mufti gj stanworth sj navarrete cv platelet refractoriness issues adverse clinical outcomes o longer hospital stay o increased bleeding risk o reduced survival o impact choice treatment underlying disease increased healthcare costs c